• A031501 Pembrolizumab in Treating Patients with Locally Advanced Bladder Cancer
  • A031702 A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers
  • A031704 PD-Inhibitor (Nivolumab) and Ipilimumab followed by Nivolumab vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated Renal cell cancer
  • AGCT1531 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients with Germ Cell Tumors  
  • SWOG S1500 Cabozantinib S-Malate, Crizotinib, Volitinib, or Sunitinib Malate in Treating Patients with Locally Advanced or Metastatic Kidney Cancer
  • SWOG S1815  Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in newly Diagnosed Advanced Biliary Tract Cancers
  • NCT01226004   Multi-Institutional Registry for Prostate Cancer Radiosurgery- (PHSW only)